IL1B and tuberculosis: A pan-group 1 caspase inhibitor, Z-WEHD-FMK, significantly reduced production of IL-1α and IL-1β, with a particularly prominent effect observed in TB-IRIS (Fig. 7), further indicating that the proinflammatory response in TB-IRIS is at least in part mediated by inflammasomes.